Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 13 (3), R101
- https://doi.org/10.1186/cc7933
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasionJCI Insight, 2007
- Association between High Levels of Blood Macrophage Migration Inhibitory Factor, Inappropriate Adrenal Response, and Early Death in Patients with Severe SepsisClinical Infectious Diseases, 2007
- Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injuryLiver International, 2006
- Macrophage Migration Inhibitory Factor: Gene Polymorphisms and Susceptibility to Inflammatory DiseasesClinical Infectious Diseases, 2005
- New therapeutic target in inflammatory disease: macrophage migration inhibitory factorInternal Medicine Journal, 2005
- MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSISShock, 2004
- Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF)Cytokine, 2004
- YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent MeningitisClinical and Vaccine Immunology, 2002
- MIF as a glucocorticoid-induced modulator of cytokine productionNature, 1995
- MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemiaNature, 1993